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udden Cardiac Death With and
ithout Left Ventricular Systolic Dysfunction
wo-Year Findings from the Oregon Sudden Unexpected Death Study
ric C. Stecker, MD, Catherine Vickers, RN, Justin Waltz, MPH, Carmen Socoteanu, MD,
enjamin T. John, MD, Ronald Mariani, EMT-P, John H. McAnulty, MD, FACC, Karen Gunson, MD,
onathan Jui, MD, MPH, Sumeet S. Chugh, MD, FACC
ortland, Oregon
OBJECTIVES We sought to evaluate the contribution of left ventricular (LV) dysfunction toward occurrence
of sudden cardiac death (SCD) in the general population, and to identify distinguishing
characteristics of SCD in the absence of LV dysfunction.
BACKGROUND Patients who manifest warning symptoms and signs are more likely to undergo evaluation
before SCD. Although prevalence of LV dysfunction in this subgroup may overestimate
the prevalence in overall SCD, this is the only means of assessment in the general
population.
METHODS All cases of SCD in Multnomah County, Oregon (population 660,486; 2002 to 2004) were
prospectively ascertained in the ongoing Oregon Sudden Unexpected Death Study. We
retrospectively assessed LV ejection fraction (LVEF) among subjects who underwent
evaluation of LV function before SCD (normal: 55%; mildly to moderately reduced: 36%
to 54%; and severely reduced: 35%). Of a total of 714 SCD cases (annual incidence 54 per
100,000), LV function was assessed in 121 (17%).
RESULTS The LVEF was severely reduced in 36 patients (30%), mildly to moderately reduced in 27
(22%), and normal in 58 (48%). Patients with normal LVEF were distinguishable by younger
age (66 15 years vs. 74 10 years; p 0.001), higher proportion of females (47% vs. 27%;
p  0.025), higher prevalence of seizure disorder (14% vs. 0%; p  0.002), and lower
prevalence of established coronary artery disease (50% vs. 81%; p  0.001).
CONCLUSIONS In this community-wide study, only one-third of the evaluated SCD cases had severe LV
dysfunction meeting current criteria for prophylactic cardioverter-defibrillator implantation.
The SCD cases with normal LV function had several distinguishing clinical characteristics.
These findings support the aggressive development of alternative screening methods to
enhance identification of patients at risk. (J Am Coll Cardiol 2006;47:1161–6) © 2006 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.045the American College of Cardiology Foundation
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Uevere left ventricular (LV) dysfunction confers significantly
ncreased risk of sudden cardiac death (SCD) and is
urrently the major indication for primary prevention with
he implantable cardioverter-defibrillator (ICD) (1–4). In
See page 1167
he absence of severe LV dysfunction, ICD implantation for
ncreased risk of SCD is limited to a small subset of
onditions, such as hypertrophic obstructive cardiomyopa-
hy, the long QT and Brugada syndromes, and idiopathic
entricular fibrillation (5). Large cohort studies have iden-
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005, accepted November 20, 2005.ified several other risk predictors, such as family history,
iabetes mellitus, obesity, and heart rate profile during
xercise (6–10), indicating that determinants of SCD are
ikely to be diverse as well as multifactorial.
In fact it has been postulated that patients with severe LV
ysfunction, such as those studied in the prospective pro-
hylactic ICD trials, may represent a minority of the sudden
eath population at risk (11–14). However, the distribution
f LV function among cases of SCD has not been evaluated
n a U.S. subpopulation. A suitable approach would be
rospective and population based, with SCD cases being
scertained from multiple sources such as first responders
nd medical examiners as well as area hospitals (13,15).
etermination of the extent and distribution of LV
ysfunction among SCD cases in the general population
s also a logical first step in the identification of novel
redictors of SCD risk among subjects who do not have
V dysfunction.
The Oregon Sudden Unexpected Death Study is an
ngoing investigation of SCD among all residents of a large
.S. community (15). To evaluate the prevalence of LV
ysfunction among SCD cases in the general population, we
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LV Dysfunction and Sudden Cardiac Death March 21, 2006:1161–6erformed a retrospective analysis of left ventricular ejection
raction (LVEF) among patients who underwent LV func-
ion evaluation before SCD. To identify distinguishing
haracteristics of SCD in the absence of LV dysfunction, we
erformed clinical comparisons between SCD cases with
vidence of LV dysfunction and those with normal LV
unction.
ETHODS
tudy population. All residents of Multnomah County,
regon (population 660,486), who experienced sudden
ardiac death between February 1, 2002, and January 31,
004, were evaluated. Cases were identified from multiple
ources: the county emergency medical response system, the
edical examiner, and area hospitals. Detailed methods
ave been published earlier (15). In order to be included in
his analysis, medical records were required with sufficient
etail such that LV function before SCD could be
stablished.
ase ascertainment. The county emergency medical ser-
ice, the medical examiner, and all public and private
ospitals participated in the study. Cases were identified by
mergency medical technicians, the office of the medical
xaminer, and emergency department physicians, and phy-
icians of record referred these cases to investigators for
creening. Missed cases were captured during weekly audits
f the ambulance run-sheets and medical examiner death
eports. Medical records were obtained from one or more of
he following sources: 1) emergency medical responders;
) medical examiner; 3) hospital of record; 4) primary care
hysician. After all available medical records were accessed,
nvestigators performed a detailed evaluation of each case,
hich included analysis of the circumstances of death,
nown medical history and any information from the index
ospitalization or autopsy. Cases were categorized as SCD
y a majority consensus of three cardiologists. Deaths were
ategorized as sudden if they met the World Health
rganization criteria (16). Witnessed SCDs were those in
hich cardiac arrests happened within 1 h of symptom
nset. Unwitnessed SCDs were those in which patients
ere found dead within 24 h of having last been seen alive
nd in a normal state of health. All patients were included,
egardless of whether they underwent resuscitation. Patients
ere excluded if death was not unexpected (e.g., terminal
Abbreviations and Acronyms
ARVD  arrhythmogenic right ventricular dysplasia
CAD  coronary artery disease
ICD  implantable cardioverter-defibrillator
LV  left ventricular
LVEF  left ventricular ejection fraction
MI  myocardial infarction
SCD  sudden cardiac deathancer) or if non-cardiac etiologies of sudden death were rdentified (e.g., trauma, drug overdose, or pulmonary
mbolism).
efinitions. Left ventricular function was categorized by
he quantitative assessment of LVEF or qualitatively
eported LVEF as follows: normal: 55%; mildly or
oderately reduced: 36% to 54%; and severely reduced:
35%. Direct quantitative measurements of EF were
sed only if confirmed as accurate in the echocardiog-
apher’s assessment.
Patients were categorized as having hypertension, previ-
us cerebrovascular accident, sleep apnea, or seizure disorder
f indicated in the medical record. Patients were categorized
s having diabetes or hyperlipidemia if directly indicated in
he medical record or if diabetes or cholesterol medications
ere noted. Coronary artery disease (CAD) was defined as
oronary artery stenosis of 50% or documentation of
revious myocardial infarction (MI), coronary artery bypass
rafting, or percutaneous coronary intervention. Acute MI
t the time of arrest referred to: 1) documented acute MI in
he medical record; 2) fresh infarction or clot identified on
utopsy; 3) typical acute injury or infarct pattern on elec-
rocardiogram (ECG); or 4) a combination of elevated
roponin/serum creatine kinase-MB fraction (CK-MB) and
ither ECG or clinical evidence for infarction. Ischemic
ymptoms were defined as pain in the chest, shoulder, arm,
pigastrum, neck, or jaw or abrupt onset of dyspnea.
ssessment for potential bias. Comparisons of age, gen-
er, socioeconomic profile, and characteristics of cardiac
rrest were performed between patients with and without
ssessments of LV function in order to assess for potential
election bias. Geographic-based socioeconomic indicators
ere determined by identifying the 2000 Census Bureau
ensus Tract for each subject based on home address. For
he purpose of comparisons, the values of several preselected
arameters (17) associated with each tract were assigned to
ll subjects residing in the tract, and mean values were
btained.
tatistical analysis. All statistical analyses were performed
sing SPSS 13.0 for Windows (SPSS Inc., Chicago, Illinois).
ontinuous variables were expressed as mean values 
tandard deviation. Significance between groups was deter-
ined using two-sided independent-sample Student
tests for continuous variables and Pearson chi-square test
or Fisher exact test if expected cell count is5) for discrete
ariables.
ESULTS
istribution of LV function among SCD cases evaluated
efore cardiac arrest. During the two-year period, 714
esidents of Multnomah County experienced SCD (annual
ncidence 54 cases per 100,000 residents). The mean age
as 66  19 years, and 40% were female. Overall, 48% of
CD cases were witnessed and 63% underwent attempted
esuscitation. Medical records from emergency medical
esponders or the medical examiner were available in 704
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March 21, 2006:1161–6 LV Dysfunction and Sudden Cardiac Deathases (98%). A total of 121 cases (17%) underwent an
ssessment of LV systolic function before SCD. There were
o significant demographic differences between those with
n assessment of LVEF and those without, aside from a
mall difference in age (Table 1). Mean age of patients with
n LVEF assessment was 70  13 years, 44 (36%) were
emale, and 80 (66%) underwent attempted resuscitation.
he LVEF was assessed by echocardiogram in 107 (88%),
y contrast left ventriculography in 13 (11%), and by
adionuclide ventriculography in 1 (1%). The exact date of
V function assessment was known in 117 cases, and the
ajority of evaluations were conducted within two years of
CD (n  74; 63%). Of the 121 cases that underwent
ssessment of LV function, 58 patients (48%) had normal
VEF, 27 (22%) had mild to moderately reduced LVEF,
nd 36 (30%) had severely reduced LVEF.
ndications for ICD implantation based on current cri-
eria. None of the 714 SCD cases underwent ICD implan-
ation before cardiac arrest. Among the subgroup that had
valuation of LV function, severely reduced LVEF was
bserved in 36 patients (30%) and would have been the most
ommon indication for prevention of SCD with a prophy-
Table 1. Comparisons Between SCD Cases T
and All Remaining Cases of SCD
LVE
(n
Age (yrs)
Female 4
Witnessed 6
Resuscitation attempted 8
SES characteristics*
Median income $41,5
Poverty (all ages)
Poverty (elderly)
Median home value $158,6
High education (Bachelor’s degree)
*SES variables are based on Census Tract data. Analysis o
residence.
LVEF  left ventricular ejection fraction; SCD  su
tachycardia.
Table 2. Clinical Characteristics of SCD Case
Reduce
Severe
(n  36)
Age (yrs) 74  11
Female 9 (25%)
Attempted resuscitation 23 (64%)
CAD 27 (75%)
Prior SCD 2 (6%)
DM 11 (31%)
Hypertension 25 (69%)
Hyperlipidemia 21 (58%)
Seizure disorder 0
Prior CVA 4 (11%)
Sleep apnea 4 (11%)
*p value for difference between any reduction in EF and nor
CAD  obstructive coronary artery disease; CVA  cerebrov
fraction; LV  left ventricular; SCD  sudden cardiac death.actic ICD. Other indications included previous cardiac
rrest without severely reduced LVEF (n 4) and high-risk
enetic conditions (n  2). Had all information been
vailable for all individuals before SCD, the majority of
ases (n  79; 65%) would not have qualified for ICD
mplantation for prevention of SCD based on current
uidelines.
istinguishing characteristics of patients with normal
V function. As shown in Table 2, patients in the normal
V systolic function subgroup were significantly less likely
o have documented CAD. Patients with normal LV
unction also had a significantly younger mean age, higher
roportion of women, and higher proportion of seizure
isorder. All eight patients with a history of seizure disorder
ad normal LV function. Average age was 60  12 years,
nd five of these patients were female. One of these patients
lso had a diagnosis of arrhythmogenic right ventricular
ysplasia (ARVD). This patient’s seizure disorder was
ttributed to an intracranial arteriovenous malformation for
hich surgical resection was performed. For the overall
ubgroup of patients with seizure disorder, the most recently
sed antiepileptic medications were phenytoin (n  2),
nderwent Evaluation of LV Function
own
21)
LVEF Unknown
(n  593) p Value
13 66  19 0.02
%) 238 (40%) 0.44
%) 279 (47%) 0.50
%) 370 (62%) 0.44
12,800 $42,200  12,800 0.59
5.5% 13  7.7% 0.53
6.2% 10  7.7% 0.97
39,600 $164,800  62,200 0.38
15% 27  16% 0.42
seven patients owing to incomplete information regarding
cardiac death; SES  socioeconomic; VT  ventricular
at Underwent Evaluation of LV Function
Normal EF
(n  58) p Value*
/Moderate
 27)
 9.1 66  15 0.01
(30%) 27 (47%) 0.03
(70%) 38 (66%) 1
(89%) 29 (50%) 0.01
(4%) 3 (5%) 1
(33%) 19 (33%) 1
(70%) 35 (60%) 0.27
(56%) 23 (40%) 0.06
0 8 (14%) 0.01
(19%) 9 (16%) 0.85
(11%) 6 (10%) 0.89
F.hat U
F Kn
 1
70 
4 (36
1 (50
0 (66
00 
13 
10 
00 
25 
mitss Th
d EF
Mild
(n
73
8
19
24
1
9
19
15
5
3
mal E
ascular accident; DM  diabetes mellitus; EF  ejection
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LV Dysfunction and Sudden Cardiac Death March 21, 2006:1161–6arbamazepine (n  3), phenobarbital (n  1), gabapentin
n  1), and unknown (n  1). Two patients had electro-
ncephalograms documented and both were abnormal, but
either had epileptiform discharges present. Each of the
our witnessed cases in our analysis had a sudden cardiac
rrest with no seizure-like activity observed either preceding
r during the event.
On comparing the medication lists of patients with
educed LV function with those of the normal LV function
roup, no significant differences were identified for antiar-
hythmic, antipsychotic, and antidepressant medications.
owever, a significantly greater proportion of the normal
V function group had an antiepileptic medication pre-
cribed (19% vs. 3%; p 0.01). The indication for prescrib-
ng antiepileptics for the two patients in the reduced EF
roup was neuropathic pain, not seizure disorder.
etailed clinical characteristics of subsets. There were 51
atients (42%) older than 75 years. Left ventricular dysfunc-
ion was significantly more prevalent among patients older
han 75 years (severely reduced LVEF: 41% of older group
s. 21% of younger group; p  0.019). Among the 80
atients (66%) who had resuscitation attempted, 7 (9%) had
ccurrence of recognized acute MI and 13 (16%) had either
cute MI or ischemic symptoms before the arrest. The rates
f MI and ischemic symptoms did not vary based on LV
unction (Table 3). Of the seven patients with recognized
cute MI, death occurred within 1 h of the onset of symptoms
n five.
A total of 112 patients (93%) had an echocardiogram
erformed, of which 41 were inpatient and 71 outpatient
chocardiograms. The most common reasons for hospital-
zation among patients with inpatient echocardiograms
ere chest pain or acute MI (n  10), congestive heart
ailure (n  7), and chronic obstructive pulmonary disease
n  3). For all echocardiograms, one or more indications
ere available in 80 patients. Common reasons listed
ncluded evaluation of LV function (n  28), dyspnea or
ongestive heart failure (n  18), and murmur and valvular
isease (n  11). Predisposing conditions for SCD were
resent in a minority of these patients, with severe aortic
tenosis in five patients and likely hypertrophic cardiomy-
pathy in one patient (septal wall thickness 19 mm). The
able 3. Diagnosis of Myocardial Infarction or Ischemic
ymptoms Among SCD Cases That Underwent
ttempted Resuscitation
Reduced EF
(n  42)
Normal EF
(n  38) p Value
TEMI 0 2 (5%) 0.22
on–STEMI 1 (2%) 4 (11%) 0.19
schemic symptoms 3 (7%) 3 (8%) 1
ny of above 4 (10%) 7 (18%) 0.25
nly subjects in whom resuscitation was attempted were analyzed.
EF  ejection fraction; SCD  sudden cardiac death; STEMI  ST-segment
levation myocardial infarction.emainder of the patients with normal LV function (includ- Ang the one with ARVD diagnosed by other means) did not
ave indicators of SCD risk on the echocardiogram.
ISCUSSION
arlier cohort studies as well as the primary and secondary
revention trials for SCD have established severe LV
ysfunction as the best available risk predictor for SCD
1–4,18,19), but U.S. population-based evaluations have
ot been conducted. The present community-based study
emonstrated that of the patients who had LV function
ssessed before cardiac arrest, 52% had some decrease in LV
ystolic function and 30% had severely decreased LV systolic
unction. Therefore, based on current LVEF guidelines for
CD prevention, only 30% would have qualified as candi-
ates for a prophylactic ICD. Overall, considering LV
ysfunction as well as other high-risk conditions, 65% of
hese patients would not have met the criteria for ICD
mplantation. Patients with SCD and normal LVEF were
ounger, more often female, more likely to have a seizure
isorder, more likely to be taking antiepileptic medications,
nd less likely to have an established diagnosis of CAD
ompared with those with an abnormal LVEF.
The frequency of LV dysfunction in SCD from a
ommunity-based study in Maastricht, the Netherlands, has
een reported (20,21). Among 200 cases of SCD with an
ssessment of LV function available, 101 (51%) had normal
VEF, defined as 0.50, and 38 (19%) had severely
educed LVEF, defined as 0.30. If the LVEF criteria
rom this study were applied to the present study, 53% of
ur cases would have had normal LVEF and 26% would
ave had severely reduced LVEF. Therefore, our results in
U.S. population show similar trends for distribution of
evere LV dysfunction. In addition to the geographic
ocation, there are several important differences in how the
wo studies were conducted. The Netherlands study was
imited to cases 20 to 75 years old, whereas our study
ncluded all ages. Because the frequency of SCD increases
ith age, older patients can account for a significant
roportion of cases. Indeed, in our study, patients over
5 years of age constituted 38% of the total SCD cohort
uring this two-year period. In addition, the present study
ollected and analyzed detailed information on comorbidi-
ies, permitting evaluation of potential alternative clinical
isk predictors of SCD. Finally, we were able to evaluate for
otential bias between the subgroups with and without
valuation of LV function.
The findings from the present study confirm the need to
dentify SCD risk predictors other than severe LV dysfunc-
ion in the general population. Severe LV dysfunction, the
urrent major risk predictor of SCD, was identified in only
0% of SCD cases. Even if all of the other risk predictors,
uch as history of resuscitated cardiac arrest, the long QT or
rugada syndromes, hypertrophic cardiomyopathy, and
RVD, were taken into account, only 35% of SCD cases
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March 21, 2006:1161–6 LV Dysfunction and Sudden Cardiac Deathould have been identified as being at high risk for SCD.
herefore, in a hypothetical ideal situation in which all of
hese cases were to be evaluated before cardiac arrest, the
ajority (65%), based on prevailing knowledge, would not
ave met criteria for SCD prevention with the ICD
1,22,23).
However, our findings identify other potential predictors
hat may enhance risk stratification for SCD in the general
opulation. The logical first step in the search for alternative
isk predictors is a clinical comparison with SCD cases that
ad normal LV systolic function (48% of evaluated cases in
he present study). This comparison showed a lower rate of
reviously diagnosed coronary artery disease in the normal
V function group. In general, there is a strong association
etween SCD and significant CAD, and prevailing knowl-
dge would suggest that acute myocardial ischemia is likely
o be the overall dominant contributor to SCD (12,15,
4,25). In an earlier autopsy evaluation during the first year
f this community-based study, 75% of overall adult SCD
ases had associated significant CAD (15). Given the
nexpected and dynamic nature of cardiac arrest, it can be
ifficult to establish whether or not acute myocardial isch-
mia was the precipitating event. Therefore, the lower
revalence of previously diagnosed CAD in the normal LV
unction group could indicate a higher prevalence of unrec-
gnized CAD, with SCD being the first and fatal manifes-
ation. Continued emphasis on reduction of established risk
actors for coronary artery disease is likely to remain valuable
or prevention of SCD (6,26).
There were other distinguishing features among patients
ith normal LVEF (Table 1). Fourteen percent of subjects
ad a known history of seizure disorder, and this condition
as found exclusively among subjects with normal LV
unction. Sudden unexpected death in epilepsy (27–31) is
ell recognized as a cause of death in patients with seizure
isorder. In population-based studies, increased seizure
requency, duration of seizure disorder, and greater use of
nticonvulsant or psychotropic medications have all been
ssociated with this condition (29,32). With findings of
ardiac autonomic abnormalities (33) and of periods of
systole in patients who were monitored during seizures
34), a case has also been made for simultaneous and related
ccurrence of seizures and heart rhythm disorders. Finally,
n a subgroup of patients with missed primary cardiac
rrhythmogenic disorders the clinical presentation of a
entricular arrhythmia can mimic a seizure (35), which
emains a distinct possibility in the patient with ARVD and
eizure disorder in the present study. Overall, a higher
roportion of subjects with normal LV function were female
s well as younger in age. An earlier study from Albert et al.
36) that evaluated gender differences among cardiac arrest
urvivors, observed that females were less likely to have
AD. However, the same study found that CAD status was
he most important predictor of cardiac arrest in women,
nd LV dysfunction the most important predictor in men
36). From a separate autopsy-based study, we have previ- 9usly reported a higher rate of unexplained SCD among
ounger women compared to men (37). In general, disease
onditions in younger age groups are more likely to have
enetic (as opposed to environmental) influences (38), and
he possibility exists that genetic factors may also contribute
o risk of SCD (39).
tudy limitations. Because this study was dependent on
he performance of LV function evaluation before SCD, the
nalysis was performed in a subgroup of total SCD cases. In
eneral, this is an inherent limitation of population-based
tudies, especially in an investigation of SCD. In as many as
0% of cases, SCD can be the first manifestation of heart
isease. Although prospective cohorts can circumvent this
imitation, the numbers of subjects studied in existing
ardiovascular cohorts may yield limited numbers of SCD
ases per year. Nonetheless, in the present study, medical
ecords from emergency medicine responders or the medical
xaminer were available in 98% of subjects, and LV function
valuation was performed before SCD in a significant
ubgroup. Because symptomatic patients with greater sever-
ty of pre-existing heart disease are more likely to have
VEF evaluated, any bias in our results is likely to reflect an
verestimation of the prevalence of LV dysfunction among
CD cases in the general population. Due to potential
emographic and socioeconomic differences between Mult-
omah County and the rest of the country, caution should
e exercised in generalizing results of this study to other
ommunities with significantly different characteristics.
onclusions. In this large U.S. subpopulation followed for
wo years, approximately one-half of the SCD cases that
nderwent evaluation before cardiac arrest had LV dysfunc-
ion, and one-third had severe LV dysfunction. Younger
ge, female gender, seizure disorder, specific medications,
nd lower likelihood of recognized CAD were identified as
istinguishing characteristics of patients with normal LV
ystolic function and SCD. Left ventricular dysfunction is a
ignificant determinant of SCD risk in the general popula-
ion, but a renewed emphasis on identifying alternative
CD risk predictors in the general population is warranted.
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